{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:16Z","timestamp":1787020636803,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health and Welfare, Republic of Korea","award":["HC16C-2254-010017"],"award-info":[{"award-number":["HC16C-2254-010017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12931-019-1055-5","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T11:03:28Z","timestamp":1557140608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of tiotropium inhaler use on mortality in patients with tuberculous destroyed lung: based on linkage between hospital and nationwide health insurance claims data in South Korea"],"prefix":"10.1186","volume":"20","author":[{"given":"Ho Cheol","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Jee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Kook","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0116-4683","authenticated-orcid":false,"given":"Yeon-Mok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"1055_CR1","first-page":"82","volume":"55","author":"ID Bobrowitz","year":"1974","unstructured":"Bobrowitz ID, Rodescu D, Marcus H, Abeles H. The destroyed tuberculous lung. Scand J Respir Dis. 1974;55:82\u20138.","journal-title":"Scand J Respir Dis"},{"key":"1055_CR2","first-page":"963","volume":"5","author":"JH Park","year":"2001","unstructured":"Park JH, Na JO, Kim EK, Lim CM, Shim TS, Lee SD, Kim WS, Kim DS, Kim WD, Koh Y. The prognosis of respiratory failure in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2001;5:963\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1055_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4046\/trd.2017.0126","volume":"81","author":"WY Kim","year":"2018","unstructured":"Kim WY, Kim MH, Jo EJ, Eom JS, Mok J, Kim KU, Park HK, Lee MK, Lee K. Predicting mortality in patients with tuberculous destroyed lung receiving mechanical ventilation. Tuberc Respir Dis (Seoul). 2018;81:247\u201355.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"1055_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1183\/09031936.00083507","volume":"30","author":"AM Menezes","year":"2007","unstructured":"Menezes AM, Hallal PC, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Pertuze J, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30:1180\u20135.","journal-title":"Eur Respir J"},{"key":"1055_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000350917","volume":"86","author":"BW Allwood","year":"2013","unstructured":"Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration. 2013;86:76\u201385.","journal-title":"Respiration."},{"key":"1055_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3346\/jkms.2015.30.6.737","volume":"30","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, Kim YW, Han SK, Yoo CG. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015;30:737\u201342.","journal-title":"J Korean Med Sci"},{"key":"1055_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5588\/ijtld.12.0351","volume":"17","author":"CK Rhee","year":"2013","unstructured":"Rhee CK, Yoo KH, Lee JH, Park MJ, Kim WJ, Park YB, Hwang YI, Kim YS, Jung JY, Moon JY, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis. 2013;17:67\u201375.","journal-title":"Int J Tuberc Lung Dis."},{"key":"1055_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2147\/COPD.S128750","volume":"12","author":"CJ Kim","year":"2017","unstructured":"Kim CJ, Yoon HK, Park MJ, Yoo KH, Jung KS, Park JW, Lim SY, Shim JJ, Lee YC, Kim YS, et al. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. Int J Chron Obstruct Pulmon Dis. 2017;12:1589\u201396.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1055_CR9","doi-asserted-by":"publisher","DOI":"10.4178\/epih\/e2014008","volume":"36","author":"L Kim","year":"2014","unstructured":"Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service national patient samples. Epidemiol Health. 2014;36:e2014008.","journal-title":"Epidemiol Health"},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1378\/chest.93.3.580","volume":"93","author":"DA Mahler","year":"1988","unstructured":"Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580\u20136.","journal-title":"Chest."},{"key":"1055_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"1055_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"1055_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720\u201335.","journal-title":"Eur Respir J"},{"key":"1055_CR14","unstructured":"Parsons LS. Reducing Bias in a propensity score matched-pair sample using greedy matching techniques. 2001. \n                    https:\/\/support.sas.com\/resources\/papers\/proceedings\/proceedings\/sugi26\/p214-26.pdf\n                    \n                  . Accessed;"},{"key":"1055_CR15","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/sim.3150","volume":"27","author":"PC Austin","year":"2008","unstructured":"Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27:2037\u201349.","journal-title":"Stat Med"},{"key":"1055_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1164\/rccm.200906-0876OC","volume":"180","author":"B Celli","year":"2009","unstructured":"Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP, Study Investigators UPLIFT. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:948\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"1055_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/jamp.2012.1012","volume":"27","author":"AG Mathioudakis","year":"2014","unstructured":"Mathioudakis AG, Kanavidis P, Chatzimavridou-Grigoriadou V, Gialmanidis IP, Amanetopoulou SG, Christopoulou E, Evangelopoulou E, Mathioudakis GA. Tiotropium HandiHaler improves the survival of patients with COPD: a systematic review and meta-analysis. J Aerosol Med Pulm Drug Deliv. 2014;27:43\u201350.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"1055_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2147\/TCRM.S194324","volume":"15","author":"HC Kim","year":"2019","unstructured":"Kim HC, Kim TH, Rhee CK, Han M, Oh YM. Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation. Ther Clin Risk Manag. 2019;15:377\u201387.","journal-title":"Ther Clin Risk Manag"},{"key":"1055_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejcts.2011.05.028","volume":"41","author":"L Bai","year":"2012","unstructured":"Bai L, Hong Z, Gong C, Yan D, Liang Z. Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs. Eur J Cardiothorac Surg. 2012;41:335\u201340.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1055_CR20","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/S0003-4975(97)80353-0","volume":"63","author":"M van Leuven","year":"1997","unstructured":"van Leuven M, De Groot M, Shean KP, von Oppell UO, Willcox PA. Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis. Ann Thorac Surg. 1997;63:1368\u201372 discussion 72-3.","journal-title":"Ann Thorac Surg"},{"key":"1055_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S1010-7940(03)00031-9","volume":"23","author":"YT Kim","year":"2003","unstructured":"Kim YT, Kim HK, Sung SW, Kim JH. Long-term outcomes and risk factor analysis after pneumonectomy for active and sequela forms of pulmonary tuberculosis. Eur J Cardiothorac Surg. 2003;23:833\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1055_CR22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.5588\/ijtld.10.0526","volume":"15","author":"RI Ehrlich","year":"2011","unstructured":"Ehrlich RI, Adams S, Baatjies R, Jeebhay MF. Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of south African studies. Int J Tuberc Lung Dis. 2011;15:886\u201391.","journal-title":"Int J Tuberc Lung Dis."},{"key":"1055_CR23","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S0954-6111(03)00255-5","volume":"97","author":"JH Lee","year":"2003","unstructured":"Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med. 2003;97:1237\u201342.","journal-title":"Respir Med"},{"key":"1055_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3346\/jkms.2011.26.2.268","volume":"26","author":"SW Lee","year":"2011","unstructured":"Lee SW, Kim YS, Kim DS, Oh YM, Lee SD. The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci. 2011;26:268\u201373.","journal-title":"J Korean Med Sci"},{"key":"1055_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4046\/trd.2014.77.4.167","volume":"77","author":"HK Yum","year":"2014","unstructured":"Yum HK, Park IN. Effect of inhaled tiotropium on spirometric parameters in patients with tuberculous destroyed lung. Tuberc Respir Dis (Seoul). 2014;77:167\u201371.","journal-title":"Tuberc Respir Dis (Seoul)."},{"key":"1055_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/15412555.2010.510160","volume":"7","author":"CE Berry","year":"2010","unstructured":"Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD. 2010;7:375\u201382.","journal-title":"COPD."},{"key":"1055_CR27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/thx.2005.040527","volume":"60","author":"JJ Soler-Cataluna","year":"2005","unstructured":"Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925\u201331.","journal-title":"Thorax."},{"key":"1055_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1378\/chest.121.5.1441","volume":"121","author":"P Almagro","year":"2002","unstructured":"Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J. Mortality after hospitalization for COPD. Chest. 2002;121:1441\u20138.","journal-title":"Chest."},{"key":"1055_CR29","first-page":"246","volume":"15","author":"YJ Ryu","year":"2011","unstructured":"Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2011;15:246\u201350, i.","journal-title":"Int J Tuberc Lung Dis."},{"key":"1055_CR30","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, et al. Durvalumab after Chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med. 2017;377:1919\u201329.","journal-title":"N Engl J Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1055-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T19:16:38Z","timestamp":1588619798000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1055-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1055-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Board of Asan Medical Center (approval number 2016\u20131028) and written informed consent was waived due to the retrospective nature of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YM Oh has received consulting\/lecture fees from GSK, MSD, AstraZeneca, Novartis, and Boehringer-Ingelheim. CK Rhee has received consulting\/lecture fees from MSD, AstraZeneca, Novartis, Takeda, Mundipharma, Boehringer-Ingelheim, Teva, and Bayer. Other authors have no financial or other potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"85"}}